Status:
COMPLETED
Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic
Lead Sponsor:
University of Virginia
Conditions:
COVID19
Eligibility:
All Genders
Up to 99 years
Phase:
NA
Brief Summary
The SARS-CoV-2 pandemic has resulted in an international shortage of the nasopharyngeal (NP) swabs used to collect sample for virological testing. This shortage has become a crisis as testing capacity...
Eligibility Criteria
Inclusion
- Individuals presenting to the site for clinical care will be evaluated for clinical screening for Covid-19 testing or other respiratory infection testing.
- Individuals felt identified clinically as needing Covid-19 testing may be approached for study participation.
- Individuals already under clinical care that have tested positive for Covid-19 will be approached for study participation.
- Volunteer health care workers who have approached the Principal Investigator
Exclusion
- Known thrombocytopenia of \<50,000 platelets/μl (risk of mild bleeding).
- Individuals presenting with an anatomically altered nasal cavity.
- Pregnant (self-reported)
- No other patients will be specifically excluded.
Key Trial Info
Start Date :
April 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04368260
Start Date
April 24 2020
End Date
August 1 2020
Last Update
February 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia
Charlottesville, Virginia, United States, 22903